首页> 外文期刊>Gastrointestinal Endoscopy >Clinical outcomes and factors related to resectability and curability of EMR for early colorectal cancer
【24h】

Clinical outcomes and factors related to resectability and curability of EMR for early colorectal cancer

机译:早期大肠癌EMR可切除性和可治愈性的临床结果和因素

获取原文
获取原文并翻译 | 示例
           

摘要

Background: EMR has emerged as an alternative therapeutic option for selected cases of early colorectal cancer (ECC). However, the factors associated with resectability and curability of EMR for ECC remain unknown. Objective: To investigate clinical outcomes and factors related to resectability and curability in ECC cases treated with EMR. Design: Retrospective study. Setting: Tertiary-care academic medical center. Patients: This study involved all patients in whom EMR was performed for ECC at Severance Hospital between March 1997 and August 2007. A total of 236 cases of ECC occurring in 231 patients (66.2% men) were enrolled. Intervention: EMR. Curative surgical resection and lymph node dissection were used in cases that were incompletely cured by EMR. Main Outcome Measurements: Resectability, curability, and recurrence. Results: Complete cure was achieved for 162 lesions (68.6%). Of the remaining 74 cases (31.4%), 69 (29.2%) were incompletely cured, and the other 5 (2.1%) had an undetermined resection status and ultimately required supplementary surgical resection for curative treatment. Location on the right side of the colon, piecemeal resection, and submucosal carcinoma were independently associated with incomplete resection, whereas depressed tumor type was independently related to incomplete cure. Among the ECC cases completely cured by EMR and followed for more than a year (n = 118), local recurrence was observed in one case (0.8%) during the median follow-up period of 39.4 months (range 12.4-123.1 months). Limitations: Single-center, retrospective study. Conclusion: Our data show that EMR is feasible and could be an effective option for treatment of ECC if the technique is applied with the appropriate indications.
机译:背景:EMR已成为部分早期大肠癌(ECC)病例的替代治疗选择。但是,与EMR用于ECC的可切除性和可治愈性相关的因素仍然未知。目的:研究EMR治疗的ECC患者的临床结局及与可切除性和可治愈性相关的因素。设计:回顾性研究。单位:三级学术医疗中心。患者:该研究涉及1997年3月至2007年8月间在Severance医院接受ECC的所有EMR患者。共纳入236例ECC病例,其中231例患者(男性占66.2%)入选。干预措施:EMR。在EMR不能完全治愈的情况下,采用手术切除和淋巴结清扫术。主要结果指标:可切除性,可固化性和复发率。结果:162个病变完全治愈(68.6%)。其余74例(31.4%)中,有69例(29.2%)未完全治愈,另外5例(2.1%)的切除状态不确定,最终需要进行辅助手术切除以进行治疗。结肠右侧的位置,小块切除和粘膜下癌与切除不完全独立相关,而肿瘤类型低下与治愈不完全相关。在通过EMR完全治愈并随访了一年以上(n = 118)的ECC病例中,有1例(0.8%)在中位随访期39.4个月(范围12.4-123.1个月)内观察到局部复发。局限性:单中心回顾性研究。结论:我们的数据表明,如果采用适当的适应症,EMR是可行的,并且可能是治疗ECC的有效选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号